Join Propel(x) in a panel discussion with experts from academia and venture capital industry as they discuss the pathway to a COVID-19 vaccine.
Moderated by Hemai Parthasarathy from Breakout Ventures, speakers include John Lewis from University of Alberta, Una Ryan from Golden Seeds and Jenny Yip from Adjuvant Capital.
Propel(x) is a Franklin Templeton Evo Nexus Incubator Portfolio Company
This site is operated by Propel(x) Inc. (“Propel(x)”), which is not a registered broker dealer. Propel(x) does not give investment advice, endorsement, analysis or recommendations with respect to any securities. All securities posted here are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. Propel(x) has not taken steps to verify the adequacy, accuracy, or completeness of the information. Neither Propel(x) nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind related to the adequacy, accuracy or completeness of any information on this site or the use of information on this site. By accessing this site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.
Certain offerings posted on the platform and so designated are offered by Hubble Investments, Member FINRA / SIPC and a fully-owned affiliate of Propel(x), located at 1 Franklin Parkway, Bldg # 930/1 – Fintech Suite, San Mateo CA 94403. Hubble Investments does not make investment recommendations and no communication, through this website or in any other medium should be construed as a recommendation for any security offered on or off this investment platform. This website is intended solely for qualified investors. Private investments are highly illiquid and risky and are not suitable for all investors. Investments in early-stage private companies should only be part of your overall investment portfolio. Furthermore, the allocation to this asset sub-class may be best fulfilled through a balanced portfolio of different start-ups. Investments in startups are highly illiquid and those investors who cannot hold an investment for the long term (at least 5-7 years) should not invest.
©2022 Propel(x). All rights reserved. Various trademarks held by their respective owners.
